[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-350650-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-350650-en":131},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","characterization-of-putative-germline-pathogenic-variants-in-27-candidate-cancer-predisposing-genes-in-813-cats-using-a-felinespecific-multiplex-targeted-sequencing","Characterization of putative germline pathogenic variants in 27 candidate cancer-predisposing genes in 813 cats using a felinespecific multiplex targeted sequencing","","A study characterizes putative germline pathogenic variants (PVs) across 27 candidate cancer-predisposing genes in 813 cats using a feline-specific multiplex targeted sequencing approach. A total of 784 variants were detected, with 13 classified as putative PVs based on predicted truncating impact, human clinical interpretation, and in silico functional predictions. Among 18 cats carrying one of these PVs, seven showed confirmed or suspected tumors. Putative PV carriers without tumors were younger on average, suggesting increasing affected proportion over time. Candidate targeted options include PARP inhibitors and immune checkpoint inhibitor immunotherapy.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/characterization-of-putative-germline-pathogenic-variants-in-27-candidate-cancer-predisposing-genes-in-813-cats-using-a-felinespecific-multiplex-targeted-sequencing/350650/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/characterization-of-putative-germline-pathogenic-variants-in-27-candidate-cancer-predisposing-genes-in-813-cats-using-a-felinespecific-multiplex-targeted-sequencing/350650.png","ImageObject",300,407,{"name":42,"@type":43},"awa","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-28","2026-09-22",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",13,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What sequencing method was used to analyze germline variants in cats?","Question",{"text":63,"@type":64},"The study developed a feline-specific multiplex targeted sequencing method and applied it to 813 cats to analyze putative PVs across 27 candidate cancer-predisposing genes.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How many putative germline pathogenic variants were classified in this study?",{"text":68,"@type":64},"A total of 784 variants were identified, and 13 variants were classified as putative PVs based on truncating impact, human variant interpretation, and in silico functional predictions.",{"name":70,"@type":61,"acceptedAnswer":71},"What relationship was observed between putative PV carrier status and tumor presence or age?",{"text":72,"@type":64},"Among cats with one of the 13 putative PVs, seven had confirmed or suspected tumors. Putative PV carriers without tumors tended to be younger than tumor-bearing putative PV carriers, suggesting affected proportion may increase over time.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},350650,1790337651,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,120,123,127],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":116,"doc_module":4,"doc_module_name":25,"category_name":117,"show_sort_weight":118,"slug":119},9,"Religion & Spirituality",20,"religion-spirituality",{"id":118,"doc_module":4,"doc_module_name":25,"category_name":121,"show_sort_weight":118,"slug":122},"World Cup","world-cup",{"id":124,"doc_module":4,"doc_module_name":25,"category_name":125,"show_sort_weight":124,"slug":126},10,"Lifestyle","lifestyle",{"id":128,"doc_module":4,"doc_module_name":25,"category_name":129,"show_sort_weight":97,"slug":130},19,"General","general",{"code":4,"msg":82,"data":132},{"doc_id":79,"user_id":133,"nickname":42,"user_avatar":134,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":124,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":145,"preview_page_count":33,"preview_urls":146},3985747858093,"https://ap-avatar.wpscdn.com/davatar_3d24733baf745e90a7e4bdd5f77d97b2","[www. nature.com/scientificreports](www. nature.com/scientificreports)  \nOPEN  \nCharacterization of putative germline pathogenic variants in 27 candidate cancer-predisposing genes in 813 cats using a felinespecific multiplex targeted sequencing  \nNamiko Ikeda1, Keijiro Mizukami1, Ryoko Yamada1,2, Hiroto Toyoda3,4, Tomomi Aoi1, Mikiko Endo1, Yusuke Iwasaki1, Daiki Kato5, Takayuki Nakagawa5, Ryohei Nishimura5, Hirotaka Tomiyasu3 & Yukihide Momozawa1,6  \nIn humans, about 5–10% of all cancers are caused by germline pathogenic variants (PVs) in cancerpredisposing genes, and their identification enables precision oncology approaches, such as surveillance for early detection, preventive medicine, and targeted therapy. Although cancer is a leading cause of death in cats, PVs have not been investigated for precision oncology. We developed a feline-specific multiplex targeted sequencing method to analyze 813 cats for putative PVs in 27 candidate feline cancer-predisposing genes. A total of 784 variants were identified, 13 of which  \nwere classified as putative PVs based on predicted truncating impact of amino acid sequence, clinical interpretation of corresponding variants in human, and in silico prediction on amino acid functions. Among 18 cats with one of the 13 putative PVs, seven (38.9%) had various types of confirmed or suspected tumor. Although PV carriers do not always develop cancer even in humans, putative PV carriers without tumors tended to be younger (1.83–16.58, years old, 9.16 years old on average) than the median age of tumor-bearing putative PV carriers (11.83 years old), suggesting that the proportion of affected cats may increase over time. Moreover, five cats with putative PVsin homologous recombination repair genes (BRCA2, RAD51C, or ATM) and two cats with those in mismatch repair genes (MSH2 and MSH6) may be candidates for targeted therapy with PARP inhibitors and immunotherapy with immune checkpoint inhibitors, respectively. These findings provide the first characterization of putative PVs in feline candidate cancer-predisposing genes, representing an important step toward genomics-informed oncology and risk stratification in cats.  \nKeywords Cat, Cancer-predisposing genes, Germline pathogenic variants, Multiplex PCR–based targeted sequencing, Precision oncology  \nFamilial aggregation of cancer has been recognized for approximately 150 years1. Currently, 5–10% of human cancers are considered to be hereditary cancer caused by pathogenic variants (PVs) in cancer-predisposing genes2, such as homologous recombination repair genes (e.g. BRCA1 and BRCA2) and mismatch repair genes (e.g. MLH1, MSH2 and MSH6) . Detection of carriers with PVs via genetic testing has enabled precision  \n1Laboratory for Genotyping Development, RIKEN Center for Integrative Medical Sciences, Yokohama, Japan.  \n2Laboratory of Veterinary Ethology, Department of Veterinary Medical Sciences, Graduate School of Agricultural and Life Sciences, The University of Tokyo, Tokyo, Japan. 3Laboratory of Veterinary Internal Medicine, Department of Veterinary Medical Sciences, Graduate School of Agricultural and Life Sciences, The University of Tokyo, Tokyo, Japan. 4Japan Small Animal Cancer Center, Tokorozawa, Japan. 5Laboratory of Veterinary Surgery, Department of Veterinary Medical Sciences, Graduate School of Agricultural and Life Sciences, The University of Tokyo, Tokyo, Japan. 6Genomics and Transcriptomics Unit, Advanced Multi-Omics Technology Division, RIKEN Center for  \nIntegrative Medical Sciences, Yokohama, Japan. [email: momozawa@riken.jp](email: momozawa@riken.jp)  \n[www. nature.com/scientificreports](www. nature.com/scientificreports)  \noncology, such as regular surveillance for early detection, preventive medicine, and targeted therapies, all of which contribute to improved clinical outcomes. PVs in cancer-predisposing genes have also been identified in other species. In dogs, where tumors are also the leading cause of death as in humans, PVs in ","cbCaig1cwwaOkf8d","https://ap.wps.com/l/cbCaig1cwwaOkf8d","pdf",2191883,"English","# Background and rationale\n# Methods: feline-specific multiplex targeted sequencing\n# Results: variant identification and PV classification\n# Clinical associations and age patterns\n# Therapeutic implications for PV carriers","[{\"question\":\"What sequencing method was used to analyze germline variants in cats?\",\"answer\":\"The study developed a feline-specific multiplex targeted sequencing method and applied it to 813 cats to analyze putative PVs across 27 candidate cancer-predisposing genes.\"},{\"question\":\"How many putative germline pathogenic variants were classified in this study?\",\"answer\":\"A total of 784 variants were identified, and 13 variants were classified as putative PVs based on truncating impact, human variant interpretation, and in silico functional predictions.\"},{\"question\":\"What relationship was observed between putative PV carrier status and tumor presence or age?\",\"answer\":\"Among cats with one of the 13 putative PVs, seven had confirmed or suspected tumors. Putative PV carriers without tumors tended to be younger than tumor-bearing putative PV carriers, suggesting affected proportion may increase over time.\"}]","Characterization of putative germline pathogenic variants in 27 candidate cancer-predisposing genes in 813 cats using a felinespecific multiplex targeted sequencing | PDF",1790090396,25,[147,151,155,159],{"page_no":22,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/d6ff24f9a12ee4b3cf49001202dbc408.webp",983,1291,{"page_no":26,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/c9fc34e641d6f9c56a30c67df88fc3a3.webp",982,1290,{"page_no":30,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/0fa98e19d9efc611db7fb63e1feebd68.webp",981,1289,{"page_no":33,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/fdaad2402aca219582dbf29c9b92954e.webp",980,1287]